[Medical treatment of Parkinson's disease].
Our understanding of Parkinson's disease (PD) has evolved. Parkinson's disease is no longer regarded a pure motor disorder, but a complex disease with motor as well as non-motor symptoms, the latter having a major impact on the quality of life of the patient as well as the caregiver. After a few years of suffering from PD, complications of therapy add invariably to the burden of the disease. Many of these complications are not volunteered by the patient or the caregiver, either due to their embarrassing nature or due to lack of insight of their causal relationship with PD or the treatment of PD. However, proper treatment of PD has to address the non-motor symptoms and the complications of therapy as well.
Waldvogel
D
D
Neurologische Praxis Luzern, Hirslanden Klinik St. Anna, Luzern. d.waldvogel@bluewin.ch
D000328:Adult; D000367:Age Factors; D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D018849:Controlled Clinical Trials as Topic; D003704:Dementia / Q000188:drug therapy / Q000209:etiology; D003863:Depression / Q000188:drug therapy / Q000209:etiology; D015259:Dopamine Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D020820:Dyskinesias / Q000188:drug therapy / Q000209:etiology; D006212:Hallucinations / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D011788:Quality of Life; D013810:Therapeutic Equivalency; D013997:Time Factors
D000978:Antiparkinson Agents; D018680:Cholinergic Antagonists; D015259:Dopamine Agents; D018491:Dopamine Agonists; D007980:Levodopa